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Rohinton J. Morris, MDMechanical assist devices are now a standard part of thearmamentarium of cardiac surgeons that manage the
ailing heart. Specifically, left ventricular assist devices con-
inue to evolve and have been approved as both bridge-to-
ransplant and destination therapy options. Biventricular fail-
re, however, engenders the need of ventricular assist devices
VAD) designed for left-sided use, or hybrid permutations of
emporary and long-term assist devices. The Syncardia Total
rtificial Heart (TAH-t) obviates the criterion for single-sided
upport by actually excising both ventricles and supporting
ight- and left-sided circulation. As such, it also removes the
ffending substrate and minimizes the pharmacologic sup-
ort required of pure assist devices. Clinical indications for
se include biventricular failure, left ventricular (LV) failure
ith prior mechanical heart valves, LV failure with sever
natomical damage (eg, ventricular septal defect or rupture),
nd intractable malignant arrhythmias.1 Our experience also
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http://dx.doi.org/10.1053/j.optechstcvs.2012.05.001includes 2 patients with severe transplant rejection and high
antibody titers that required support, as well as removing as
much of the offending antigen as possible. Since being ap-
proved as a bridge-to-transplant device in 2004, multiple
studies have confirmed the superior survival of the TAH-t to
biventricular assist devices in patients with biventricular fail-
ure.2 Patient selection is still the mainstay of increased sur-
vival, and appropriate referral of patients before end organ
damage has occurred is paramount. The TAH-t is con-
structed with mechanical valves and thus requires a rigorous
anticoagulation regimen. Although the TAH-t is intrapericar-
dial and no extraneous pockets have to be developed, as in
VADs, appropriate sizing is necessary prior to patient selec-
tion. Most often this is done with chest x-rays and computed
tomography scanning to measure chest anteroposterior di-
ameter and assess lung volumes.3
The clinical application of the TAH-t is well-proven as a
bridge-to-transplant device, and studies are underway to test
the device as an option for destination therapy. Presented
herein is the surgical implantation technique for a unique
device.
The syncardia total artificial heart 155Operative Technique
Figure 1 Standard aortic and bicaval cannulation is performed. The cava are snared and the cross-clamp is applied as
proximally as possible to preserve aorta for eventual transplant if needed.
156 R.J. MorrisFigure 2 Excision of the heart consists of 4 main steps. The first 3 steps are as follows. 1. Initial incision into the right
ventricle 1-2 cm from the atrioventricular groove. With visualization of the tricuspid valve, the right ventricle is
detached by cutting a leaflet 1 cm from the annulus. 2. The incision is carried to the base, across the septum, and into
the LV. With visualization of the mitral valve, LV is detached by cutting the mitral leaflets 1 cm from the annulus. 3.
Incision in both aorta and pulmonary arteries, as far proximally as possible, just above the point of commissural
attachment.
The syncardia total artificial heart 157Figure 3 The fourth step in the excision of the heart. After cutting through the remnant of the aortic and pulmonary
valves, the remaining attachments of the ventricles are excised with direct visualization of the mitral and tricuspid
annuli.
158 R.J. MorrisFigure 4 The atrial appendage is ligated and the coronary sinus
is sewn shut from within the right atrium. Annuli are but-
tressedwith felt strips of 1 cmwidth. Two or 3 continuous 3-0
prolene sutures (MH needle [Ethicon, Somerville, NJ]) work
best. Note that septum will not have felt buttressing.
The syncardia total artificial heart 159Figure 5 Atrial cuffs are trimmed to 1 cm, then inverted, and placed within the cavity of the atria. Left atrial cuff is
sutured first for easier access.
160 R.J. MorrisFigure 6 Atrial cuffs are sewn with similar 3-0 prolene su-
ture. Repair figure-of-8 sutures should be placed on any
uneven segments. After eversion, cuffs can be tested. Tem-
porary pulmonary vein occlusion by pressure will assist
left-sided testing.
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The syncardia total artificial heart 161Figure 7 Arterial outflow connectors, which should
ave been preclotted or sprayed with CoSeal sepa-
ately, are sized and cut for connection. The aortic
raft is generally cut to 3-4 cm, and the PA graft cut to
-7 cm, to allow the PA graft to overlay the aortic graft,
hich will have the posterior ventricular connection.
he anastomoses are constructed with running 4-0
rolene sutures. Testing is performed with occlusion
f the PA and with the cross-clamp on.
162 R.J. MorrisFigure 8 Both ventricular pumps are brought into the wound with their drivelines percutaneously withdrawn from the
anterior abdominal wall. With the de-airing vent in place in the ascending aorta, the left pump is attached.
The syncardia total artificial heart 163Figure 9 (A) The right ventricular pump is attached in a similar manner. Caval snares can be loosened to allow filling of
the atrial chambers. (B) Gore-tex (Gore Medical, Flagstaff, AZ) sheets are sewn into the pericardial well with a few 4-0
prolene sutures. After coming off bypass, and hemostasis is achieved, the sheets can be wrapped around the ventricles
to prevent harm on reentry. (C) Percutaneous lines exit 6-8 cm from left subcostal margin.
164 R.J. MorrisPositioning Ventricular Pumps
Important notes on positioning of the ventricular pumps:
● Care must be taken to ensure twisting or kinking of the
grafts does not occur.
● Release of the left pleural attachments of the pericar-
dium will allow the left ventricular pump to be posi-
tioned more posteriorly.
● Awareness of the compression of the inferior vena cava
by direct pressure from the right ventricular pump
should be paramount. Anchoring the ventricle to a rib or
fascia may be helpful.
● Transesophageal echocardiography is essential and has
to be monitored closely when beginning pumping.
Pumping should be very slow to begin and the aortic
root vent should be as high as possible.
● Closure of the chest may change positions and close
monitoring of right atrial pressure and filling character-
istics is cardinal in importance.
● Chest closure with a Gore-tex sheet may be necessary
until the chest accommodates to space issues.Conclusions
The TAH-t is a unique device designed to support biventricu-
lar failure. Its greatest advantage may be that the technique of
implantation removes the substrate of a damaged heart. Is-
sues such as thrombus formation in the native heart, arrhyth-
mia management, and intracardiac monitoring are averted.
Discussions of long-term use, patient mobility, and drug reg-
imens are beyond the scope of this article. Although appear-
ing to be a more extensive operation than a VAD insertion,
cardiac surgeons will recognize the tenets of heart transplan-
tation in the technique presented.
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